Rigel Pharmaceuticals (RIGL) Change in Acquisitions & Divestments (2010 - 2026)

Rigel Pharmaceuticals' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $15.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 43.65% year-over-year to $15.9 million; the TTM figure through Mar 2026 stood at $66.0 million (up 55.05% YoY), while the FY2025 annual figure was $61.1 million, up 53.98% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $15.9 million, up from $13.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $29.8 million in Q1 2022, with the low at $6.0 million in Q4 2023.
• The 5-year median for Change in Acquisitions & Divestments is $15.6 million (2023), against an average of $15.3 million.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments surged 2002.72% in 2022, then sank 71.95% in 2023.
• Rigel Pharmaceuticals' Change in Acquisitions & Divestments stood at $21.2 million in 2022, then slumped by 71.65% to $6.0 million in 2023, then increased by 12.5% to $6.8 million in 2024, then surged by 100.73% to $13.5 million in 2025, then gained by 17.68% to $15.9 million in 2026.
• Business Quant data shows RIGL's Change in Acquisitions & Divestments at $15.9 million in Q1 2026, $13.5 million in Q4 2025, and $20.7 million in Q3 2025.